Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Announces Faraday Future’s Outlook for 2026
-
Argentine Football Association (AFA) teams with Verofax to offer AI Experiences to Fans
-
Argo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
UPPF Opens Shanghai Technical Center to Accelerate Product Support, Quality Management, and Installer Training
-
Cook and Will County Attorney Highlights Illinois Legal Changes Taking Effect in 2026
-
VARON Introduces VP-8 Lite: Portable, Reliable Oxygen Support to Start 2026
-
Zymeworks Outlines Strategic Priorities and Outlook for 2026
-
Esperion Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
-
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
-
Java World Mag Provides Follow-Up Context on Previously Reported Brian Ferdinand's Protective Federal Filing
-
Java World Mag Provides Follow-Up Context on Previously Reported Brian Ferdinand's Protective Federal Filing
-
Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion
-
Hyun Woo Kim, President and CEO of the Seoul Business Agency: "The Global Innovation Forum, bringing together startup ecosystem leaders from seven countries, will mark a milestone in innovation a
-
Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
-
Missed SOL? Join Apeing, Next Crypto Alert
-
HealthEx Partners with Anthropic to Turn Patients’ Scattered Medical Records into Actionable Health Insights
-
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
-
Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
-
Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
-
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results
-
Kura Oncology Highlights Recent Accomplishments, Preliminary KOMZIFTI Revenue and Anticipated 2026 Milestones
-
Beam Therapeutics Sets Strategic Priorities for its Genetic Disease and Hematology Franchises to Drive Execution of Late-Stage Clinical Programs and Extends its Operating Runway through Commercial Tra
-
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
-
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
-
Bitget Listed Lowest Trading Fees Across Major Crypto Exchanges
-
Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results
-
Joint Statement Regarding Resolution of Litigation Between Aristocrat and Light & Wonder
-
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
-
Allegiant and Sun Country Airlines to Combine, Creating a Leading, More Competitive Leisure-Focused U.S. Airline
-
Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026
-
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
-
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
-
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
-
Visual AI Takes Center Stage at CES 2026: FIRSTHABIT’s ‘Chalk 4.0’ Becomes the Silicon Valley of Eureka Park
-
Rich Sparkle Holdings Closes Acquisition of TikTok Icon Khaby Lame's Core Company
-
Vibe Retail POS Sets the Standard for Retail-Focused Point-of-Sale Technology
-
REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy Program
-
Molecular Partners Highlights Clinical Development Progress and Anticipated Milestones at 44th Annual J.P. Morgan Healthcare Conference
-
Exagen Inc. Announces Select Preliminary 2025 Financial Results
-
Central Texas Angel Network Spotlighted on The Building Texas Show for Statewide Impact on Startup Investment
-
Direct Source Highlights the Hottest Retail Technology Innovations at NRF Big Show 2026
-
Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome
-
Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
-
Speediance Brings the Future of Smart Home Fitness to Life at CES 2026
-
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference
-
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
-
Debiopharm Deploys Genialis Software to Advance AI-Based Biomarker Discovery
-
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era
-
Kepler Successfully Launches First Tranche of Optical Relay Satellites
-
T.R.O.N. Podcast Launches New Season with Fresh Expert Interviews

